% | $
Quotes you view appear here for quick access.

Albany Molecular Research Inc. Message Board

  • mba2b mba2b Mar 18, 1999 9:48 PM Flag

    Ahhh! Allegra!

    With AMRI's fees from Hoechst for Allegra the
    income statement may be distorted. I would try to
    determine what the company can do without those fees. You'd
    probably find it's on par with a specialty chemical
    company and not a drug company.

    They do have a
    head start in this business (Oxford in England has
    thrown its hat in the ring) and other small players are
    on the horizon. Provided they can grow the core
    business it could be a good stock to own.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
20.00+0.17(+0.86%)Nov 25 4:00 PMEST